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Background: Obstructive sleep apnoea (OSA) in pregnancy is associated with an increased morbidity and mortality to both 
mother and foetus. In the South African setting the proportion of pregnant females suffering from OSA has not been well 
studied; nor has the association with pre-eclampsia. This study aimed to determine the prevalence of OSA in females before 
35 weeks gestation using the STOP-BANG questionnaire and to determine the association with pre-eclampsia in a local South 
African setting.
Methods: A cross-sectional analytical study including 234 patients was conveniently sampled from Kalafong Hospital’s antenatal 
ward, clinic and labour ward. Participants were of more than 20 weeks and less than 35 weeks gestation. All participants were 
interviewed with a modified STOP-BANG questionnaire. Patients were consecutively enrolled without prior knowledge of the 
presence of pre-eclampsia. At Kalafong hospital all pregnant patients are routinely screened and investigated for pre-eclampsia 
according to standard criteria.
Results: The median gestational age in this sample was 28 weeks; 80.3% (CI 74.62–85.2%) of pregnant females had a low risk for 
OSA, 15.4% (CI 11.01–20.65%) had an intermediate risk and 3% (CI 6.47–14.58%) had a high risk for OSA. A modified STOP-BANG 
questionnaire had a sensitivity of 62.5% and a specificity of 82.1% for pre-eclampsia when a score of 3 and more was scored. 
Females at high risk of OSA had an OR of 8.4 (CI 2.88–24.6) for having pre-eclampsia.
Conclusions: The authors report 15.4% of the study’s pregnant population to be at intermediate risk and 3% at high risk of OSA. 
The association between the hypertensive disorders and OSA must be considered and screening implementation considered.
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Introduction
Recently, interest has been shown in pregnant females suffering 
from obstructive sleep apnoea (OSA) because of the association 
with hypertensive disorders and an increased perinatal morbidity 
and mortality for mother and baby.1–3 Continuous positive airway 
pressure (CPAP) treatment in patients with pre-eclampsia has 
been shown to decrease blood pressure and improve cardiac 
output in comparison with no treatment.4
In the USA the highest prevalence of OSA in pregnancy is among 
obese patients, with an increasing prevalence towards the 
second and third trimester. The South African prevalence has not 
been investigated; however, due to high rates of obesity, OSA is 
expected to be high. Surveys have shown that 90% of pregnant 
patients with OSA are unaware of their condition.1
The normal physiological changes during pregnancy predispose 
to snoring. The oropharyngeal diameter narrows and the 
Mallampati grade increases as the pregnancy progresses.5,6 The 
nasal passages narrow from mucosal oedema and increased 
negative pharyngeal pressure is required with inspiration to 
overcome the increased upper airway resistance. Sleep decreases 
pharyngeal muscle tone further.5,6 These changes lead to an 
increase in upper airway obstruction resulting in a spectrum of 
sleep-disordered breathing patterns. OSA leads to intermittent 
hypoxia associated with increases in blood pressure.1
The reference standard for diagnosing OSA is an overnight 
polysomnogram. This is expensive, time-consuming and not 
practical for the majority of the South African population. 
Screening questionnaires like the STOP-BANG have been 
validated to identify OSA in pregnancy.4,7 Lockhart et al.8 showed 
the STOP-BANG questionnaire to have the highest specificity 
(85%) and to have performed the best out of six screening tools. 
The STOP-BANG questionnaire takes common signs and 
symptoms of OSA into account and a score out of 8 is derived 
Each increase in the STOP-BANG score is associated with an 
increase in the probability of OSA and the severity of OSA.4,9 A 
score of 0–2 indicates a low risk, a score of 3–4 indicates an 
intermediate risk and a score of ≥ 5 indicates a high risk for OSA.10
During pregnancy weight gain can be attributed to oedema, 
increase in blood volume, foetal tissue and amniotic fluid. A 
study done on parturients in the Metro West area of Cape Town 
showed a strong correlation between body mass index (BMI) and 
mid-upper arm circumference (MUAC) up to 30 weeks gestation.11 
In their study including 2912 pregnant females, Cooley et al.12 
also showed a correlation between BMI and MUAC that can be 
calculated as BMI  = MUAC(cm) +/– 2 cm. MUAC is a much easier 
measurement to take as it does not necessitate using scales, 
height charts or calculations. Another advantage is that there is 
minimal change in MUAC during pregnancy, which is a good 
indicator of pre-pregnancy body fat and nutrition.11 In this study 
we modified the STOP-BANG questionnaire using MUAC rather 
than BMI.
Pre-eclampsia is defined as new-onset hypertension and proteinuria 
or end organ damage after 20  weeks gestation.13 New-onset 
snoring during pregnancy is a strong risk factor for gestational 
hypertension and pre-eclampsia. A correlation between a positive 
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score on the STOP-BANG and pre-eclampsia has also been proven.14 
In the USA, females diagnosed with OSA on polysomnogram have a 
19.3% higher risk of having pre-eclampsia.2
The aim of this study was to determine the prevalence of OSA in 
females before 35 weeks gestation using a modified STOP-BANG 
questionnaire and to determine the association of OSA and pre-
eclampsia in a local South African setting.
Methods
A cross-sectional analytical study was conducted. A convenience 
sample of patients was taken from patients admitted to the 
antenatal ward, labour ward or attending the antenatal clinic at 
Kalafong Hospital, without prior knowledge of the diagnosis or 
comorbidities. Each participant had to be 18 years or older, and 
be more than 20  weeks but less than 35  weeks pregnant. At 
Kalafong Hospital patients with pre-eclampsia are routinely 
delivered by 35 weeks, which determined our inclusion criteria.
Kalafong Hospital is a tertiary institution providing services to 
uninsured urban inhabitants of the south-western districts of the 
greater Tshwane. Patients are mostly from a lower socio-
economic background and are predominantly African. The 
obstetric unit provides care to a large spectrum of patients from 
low-risk to high-risk pregnancies.
Recruitment was initiated from 11 February 2015 until 6 March 
2015. Each participant was interviewed only once. Only one 
interviewer enrolled participants and assisted with the 
completion of a set questionnaire. The study was approved by 
the Ethics Committee of the Faculty of Health Sciences of the 
University of Pretoria (Protocol approval nr: 5/2015). All 
participants approached for enrolment to the study were 
informed about all study procedures and what would be 
expected of them. Once participants indicated willingness to 
participate an informed consent document was signed. All 
patients attending the antenatal clinic, or those who were 
admitted to the ward, were approached for enrolment to the 
study. Demographic details such as age, race, parity, gravidity, 
and previous abortions were recorded. Other comorbidities like 
asthma, diabetes, smoking, other renal disease, pre-eclampsia 
and HIV status according to the patient if known were recorded.
The STOP-BANG questionnaire has eight questions. Participants 
in this study automatically scored 0 for age (above 50) and male 
gender. For each positive answer a patient scored one mark. The 
following questions were asked:
Modified STOP-BANG questionnaire
1. Do you snore?
2. Do you feel tired to such an extent that you fall asleep during a conversation or in circumstances endangering yourself or 
others?
3. Has anyone observed you choking or gasping while sleeping?
4.  Do you have hypertension – new onset or prior?
5.  MUAC ≥ 33 cm
6. Neck circumference > 40 cm
The STOP-BANG questionnaire utilises BMI as one of its scoring 
points. To simplify the BMI in pregnancy, Cooley et al. used the 
MUAC as a surrogate. A correlation between BMI and MUAC was 
clearly demonstrated. The BMI can easily be calculated by a 
simple equation where BMI  = MUAC +/– 2 cm. In this study we 
substituted BMI with MUAC.12 By doing so we modified the STOP-
BANG questionnaire. Mid-upper arm circumference was 
measured and if 33 cm or more a positive mark was scored. The 
right upper arm was measured at the midpoint between the tip 
of the acromion and the tip of the olecranon. Neck circumference 
greater than 40  cm also scored one mark. Measurement was 
made around the neck in a horizontal plane at the level of the 
most prominent portion of the thyroid cartilage.
Pre-eclampsia was diagnosed as new-onset hypertension after 
20  weeks gestation with proteinuria or end organ damage. 
Hypertension was classified as SBP > 140 mmHg or DBP > 90 mmHg 
and proteinuria > 1+protein on urine dipsticks or 0.3 g/24 h. End 
organ damage is classified as platelet count  <  100  000ug/l or 
doubling of serum creatinine or elevated transaminase.
The primary aim of the study was to determine the proportion of 
females at Kalafong’s obstetric unit who are at risk of OSA. A 
secondary aim was to relate OSA to pre-eclampsia.
Statistical analysis
A sample size of 196 participants was calculated to be sufficient 
to estimate the proportion of patients at risk for OSA during 
pregnancy (primary aim) with an accuracy of 5%, assuming an 
anticipated proportion of OSA of about 15% and a CI of 95%.
The primary outcome of the study was to determine the 
proportion of patients with OSA based on the STOP-BANG score. 
The STOP-BANG score, however, does not make a definitive 
diagnosis of OSA and only indicates the risk as low, moderate 
and high for OSA. The proportion of patients in each of these risk 
categories was calculated with related 95% confidence intervals.
A chi-square test for trend was done to relate the risk categories 
of OSA to the presence of pre-eclampsia.
Additional analysis included a logistic regression modelling 
where relevant potential risk factors and confounders were 
entered to adjust for potential confounding with the STOP-BANG 
as dependent variable. This was also repeated with pre-eclampsia 
as dependent variable and the STOP-BANG as independent 
variable with other risk factors and confounders.
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The performance and accuracy of STOP-BANG as diagnostic 
indicator of pre-eclampsia was done with ROC statistics without 
adjusting for confounders.
Results
Pregnant patients were consecutively recruited from the 
Antenatal Clinic and ward at Kalafong hospital. A number of 
patients were excluded after being approached for inclusion 
based on the exclusion criteria for the study (Figure 1). A total of 
234 participants were interviewed and measured.
Of the pregnant women enrolled only 18 (7.7%) were not African. 
The majority of participants 97 (41.1%) were para 1 and 54 
(23.1%) para 2. A large proportion of the patients 63 (26%) had 
had a previous spontaneous abortion or termination of 
pregnancy. Among the participants 45 (19.2%) were HIV positive 
although 15 patients did not know their HIV status.
Of the 234 patients included in the study 47 (20.1%) had a 
premorbid medical condition of which hypertension 17 (7.2%) 
was the most prevalent. Fourteen (5.98%) of the patients enrolled 
had a condition that complicated pregnancy or delivery (Table 1).
Table 2 indicates the proportion of pregnant patients with 
different scores on the STOP-BANG questionnaire. This means 
that 188 patients (80.3%, CI 74.62–85.2%) were at low risk (score 
0 to 2), 36 patients (15.4%, CI 11.01–20.65%) were at moderate 
risk (score 3 to 4) and 10 (3%, CI 6.47–14.58%) were at high risk 
(score 5 to 8) for obstructive sleep apnoea.
If hypertension due to pre-eclampsia is also included in the 
scoring of the STOP-BANG score: 6 (3.2%) patients had pre-
Approached for
participation
(n = 266)
Excluded
(n = 28)
Six patients refused
participation  
Four patients were
enrolled twice
Six patients were
younger than 18 years
12 patients fell outside
the gestation range
Included
(n = 234)
Age≥ 18 years
Gestation≥ 20 weeks
and≤ 35 weeks   
Figure 1: Patient flow.
Table 1: Patient characteristics and demographics
Variable n  = 234
Age (mean, standard deviation) 30 (25–36)
Race: African 216 (92.3%)
Other 18 (7.7%)
Parity, median (range) 1 (0–7)
Gravida median (range) 3 (0–9)
Gestational age (median, IQR) 28.5 (24–32)
HIV status positive 45 (19.2%)
Comorbid medical conditions
 Hypertension pre-conception 17 (7.2%)
 Asthma 11 (4.7%)
 Diabetes 10 (4.3%)
 Renal disease 6 (2.6%)
 Cardiac disease 2 (0.8%)
 Epilepsy 1 (0.4%)
Comorbid conditions and complications associated with 
pregnancy
 Fibroid uterus 1 (0.4%)
 HELLP syndrome 1 (0.4%)
 Intrauterine growth restriction 1 (0.4%)
 Previous pre-eclampsia 1 (0.4%)
 Placenta previa 2 (0.9%)
 Preterm labour 3 (1.3%)
 Premature rupture of membranes 2 (0.8%)
 Pyelonephritis 1 (0.4%)
 Twin pregnancy 2 (0.8%)
Table 2: STOP-BANG criteria and proportions of patients with each 
criterion
*Gender was excluded due to the population of the study.
Criterion n (%) fulfilling the 
criterion
Mean (SD)
Do you snore loudly? 89 (38%)
Do you often feel tired, 
fatigued, or sleepy during 
daytime?
39(16.7%)
Has anyone observed 
you stop breathing while 
sleeping?
26 (11.1%)
Do you have or are you 
treated for hypertension 
(including pre-eclampsia)
46 (19.7%)
Mid-upper arm circumfer-
ence ≥ 33 cm (replacement 
for BMI in pregnancy)
97 (41.5%) 32 (4.7)
Neck circumference > 40 cm 13 (5.6%) 35.7 (2.88)
0
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Figure 2: ROC curve for STOP-BANG diagnosing pre-eclampsia.
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high BMI. The median patient age in this study was 28  weeks; 
thus results in a term population may look different. The 
incidence of pre-eclampsia has increased by one-third in the last 
decade.16 This could correspond to the increase in obesity, which 
is an independent risk factor for OSA and pre-eclampsia.15,17 The 
median BMI for a pregnant South African female is 32, which 
places her in the obese group and increases her risk for OSA. The 
prevalence of pre-eclampsia in this sample was 6.8%.
Because hypertension is part of the STOP-BANG criteria and is a 
major finding in pre-eclampsia, if patients without pre-
pregnancy hypertension are considered as hypertensive on the 
STOP-BANG score it may lead to incorporation bias, which may 
lead to over-diagnosis of OSA. This may be one of the limitations 
of using the STOP-BANG score during pregnancy.
Chung et al.18 showed how specific combinations of components 
of the STOP-BANG improved the specificity of the questionnaire. 
Patients with a STOP score of ≥ 2, male gender and a BMI greater 
than 35 kg/m2 were more predictive of OSA than age greater or 
equal to 50 and neck circumference  >  40  cm.18 Another 
combination that was looked at was a STOP-BANG score  >  2 
combined with serum bicarbonate of at least 28 mmol/l, which 
indicated a higher risk of moderate to severe OSA.8,18 BMI greater 
than 35  kg/m2, falling asleep while talking to someone and a 
history of hypertension are found to be significant independent 
predictors of OSA. Combining the above components to devise a 
screening tool specific for the pregnant population to diagnose 
OSA needs further investigation. Two risk factors for pre-
eclampsia (chronic hypertension and increased BMI) are two 
questions on the STOP-BANG questionnaire, and may influence 
the prediction of pre-eclampsia.
In the pregnant population we propose a score that looks at the 
following components: snoring, tiredness, witnessed obstruction, 
hypertension, BMI  >  35  kg/m2 or a MUAC  >  33  cm and 
bicarbonate > 28 mmol/l. These values need to be validated against 
formal sleep studies in the pregnant population. In the majority of 
public patients in South Africa an overnight polysomnogram is 
practically impossible to perform due to limited resources and 
patient willingness. The clinician should be alerted to the high 
possibility of OSA and its complications with a positive score on the 
above components. Patients with OSA are more sensitive to the 
sedative effects of central acting agents, e.g. opioids and 
benzodiazepines, which increases the risk of postoperative upper 
airway obstruction.19 Opioids induce or worsen obstructive 
breathing in all patients.20 Non-sedating pharmacology and 
regional techniques should be implemented as far as possible.20 
Whitehead et al.21 reported a case where early pre-eclampsia 
associated with severe sleep-disordered breathing was treated 
with CPAP. The clinical and biochemical markers of pre-eclampsia 
improved and the pregnancy could continue for an extra 30 days.
eclampsia in the low-risk category, 8 (22.2%) patients had pre-
eclampsia in the intermediate risk category and 2 (20%) had pre-
eclampsia in the high-risk category (chi-square for trend 
p < 0.001).
Of the 234 patients included in the study 16 (6.8%) had pre-
eclampsia. A ROC curve analysis was done which indicated that a 
cut-off of 2 STOP-BANG criteria has the best trade-off between 
sensitivity (81.25%, CI 54.4–96.0) and specificity (64.68%, CI 57.9–
7.0) for diagnosing pre-eclampsia during pregnancy (AUC 0.805, 
CI: 0.748 to 0.853) (Figure 2). The accuracy of the STOP-BANG 
score in diagnosing pre-eclampsia at different cut-off values is 
displayed in Table 3. However, a score of 3 or more is required to 
be categorised into a high-risk group, which is clinically relevant. 
A cut-off of 3 or more had a sensitivity of 62.5% and a specificity 
of 82.11% for diagnosing OSA.
A STOP-BANG score of 3 or more had an OR of 8.4 (CI 2.88–24.6) 
for pre-eclampsia and a relative risk ratio was calculated to be 6.8 
(CI 2.24–22.8). The questionnaire showed a high negative 
predictive value of 96.8% if a score of 3 or more was achieved.
Multiple logistic regression was done to evaluate factors that 
may increase or reduce the Odds ratio of the STOP-BANG score to 
predict pre-eclampsia (hypertension only included pre-
conception hypertension). The following independent variables 
were investigated in a univariate analysis: gestation age (p = 
0.787), gravidity (p = 0.303), patient age (p = 0.02), race (p = 
0.416), current smoking (p = 0.502), and HIV positivity (p = 0.635). 
Of these only age was significant (p < 0.2) in a univariate analysis 
to be included in a multivariate model. In the multivariate model 
age was not significant and did not change the performance 
with only the STOP-BANG score of ≥ 2 (OR 4.55, CI 1.525–13.6, p  
= 0.007).
Discussion
The main results showed that 80.3% of pregnant females had a 
low risk for OSA, 15.4% had an intermediate risk and 3% had a 
high risk for OSA. If a score of 3 or more was scored the individual 
had an 8.4 higher odds of having pre-eclampsia as well and a 
relative risk for pre-eclampsia 6.8 times higher than if she had no 
OSA. This corresponds to other studies, which showed a 6.1 
higher odds of having pre-eclampsia with a positive score on the 
STOP-BANG.14 The high negative predictive value of 96.8% of the 
STOP-BANG score means that patients scoring  <  3 can be 
considered to be at low risk for OSA and do not have to undergo 
any further formal sleep studies.
OSA in pregnancy in the USA has a prevalence of 11–20%; this 
corresponds to our at-risk group of 18.4%.15 The highest 
prevalence of OSA in the US group was in obese patients.15 In our 
study group 41.5% of participants scored positive due to their 
Table 3: Accuracy of STOP-BANG scores for different cut-off values
Criterion Sensitivity 95% CI Specificity 95% CI +LR 95% CI −LR 95% CI
One or more 100.00 79.4−100.0 42.20 35.6−49.1 1.73 1.5−1.9 0.00
Two or more 81.25 54.4−96.0 64.68 57.9−71.0 2.30 1.7−3.1 0.29 0.1−0.8
Three or more 62.50 35.4−84.8 82.11 76.4−87.0 3.49 2.2−5.6 0.46 0.2−0.9
Four or more 31.25 11.0−58.7 90.83 86.2−94.3 3.41 1.5−7.9 0.76 0.5−1.1
5 or more 12.50 1.6−38.3 95.87 92.3−98.1 3.03 0.7−12.9 0.91 0.8−1.1
Six 0.00 0.0−20.6 98.62 96.0−99.7 0.00 1.01 1.0−1.0
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Conclusion
In the local South African setting a convenience cohort found 
18.4% of pregnant females (median gestation of 28 weeks) to be 
at risk of suffering from OSA as assessed by a modified STOP-
BANG questionnaire. Our reported incidences correspond to 
international studies. The previously reported association 
between OSA and pre-eclampsia was confirmed in our study. 
Future studies need to focus on early treatment of OSA when 
associated with pre-eclampsia, so that the clinical and 
biochemical picture of pre-eclampsia may be potentially 
reversed and the intra-uterine gestation prolonged.
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